Several recent in vitro and in vivo studies20, 23, 25 and clinicopathological investigations18, 19, 23, 25 have exhibited that the dysregulation of ADAMTS4 expression promotes tumor progression and angiogenesis by modifying pVEGFR2. The gene discussed is ADAMTS4; the disease is neoplasm.